Shankar Siva

University of Melbourne

Australia

Research Interests

Explore related searches

Professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Sung Jun Ma

Assistant Professor

UNITED STATES

View details

Hiroshi Onishi

University of Yamanashi

JAPAN

View details

Tomas Kron

University of Wollongong

AUSTRALIA

View details

Mark Farrugia

Assistant Professor

Roswell Park Comprehensive Cancer Center

UNITED STATES

View details

Evan Hall

Assistant Professor

University of Washington

UNITED STATES

View details

Xenia Ray

Assistant Clinical Professor

Moores Cancer Center, UC San Diego Health

UNITED STATES

View details

Benjamin Solomon

Professor

University of Melbourne

AUSTRALIA

View details

Bradley McGregor

Harvard University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shankar Siva

Research Interests

Explore related searches

Contact this professor

Articles (10)

Characterization of FOLH1 Expression in Renal Cell Carcinoma

Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases

Metastatic Ablation in Epidermal Growth Factor Receptor Mutated Oligometastatic Non-Small Cell Lung Cancer-Upfront or Outback After Systemic Tyrosine Kinase Inhibitors?

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma

The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?

Re: Fifteen-Year Outcomes After Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Systematic Review of Single-Fraction Stereotactic Body Radiation Therapy for Early Stage Non-Small-Cell Lung Cancer and Lung Oligometastases: How to Stop Worrying and Love One and Done

Impact of Medical Operability and Total Metastatic Ablation on Outcomes After SABR for Oligometastases

Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions

Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer

Collaborators (8)

Sung Jun Ma

Hiroshi Onishi

Tomas Kron

Mark Farrugia

Evan Hall

Xenia Ray

Benjamin Solomon

Bradley McGregor

Make your next move.